Journey Medical Corporation (DERM) Stock Overview
Explore Journey Medical Corporation’s financial performance, market position, analyst ratings, and future outlook.
Journey Medical Corporation (DERM)
Key Financials
Key Financials
Market Cap
213.3M
P/E Ratio
-34.13
EPS (TTM)
$-0.37
ROE
-0.20%
DERM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Journey Medical Corporation (NASDAQ: DERM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Journey Medical Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of DERM on the NASDAQ shows an RSI of 70.37, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $7.72 for the NASDAQ listing.
Key metrics behind Journey Medical Corporation's NASDAQ-traded stock include a P/E ratio of -34.13 and a market capitalization of 213.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of DERM on the NASDAQ.